Nanotechnology Now – Press Release: Arrowhead Presents New Clinical Data on Cardiometabolic Pipeline at AHA 2020

Home > Press > Arrowhead Presents New Clinical Data on Cardiometabolic Pipeline at AHA 2020Abstract:- ARO-APOC3 achieved triglyceride reductions of 74-92%- ARO-ANG3 achieved triglyceride reductions of 29-75% and LCL-C reductions of 29-35%- Company to host upcoming KOL webinars on ARO-APOC3 and ARO-ANG3 Arrowhead Presents New Clinical Data on Cardiometabolic Pipeline...

Nanotechnology Now – Press Release: Arrowhead Interim Clinical Data Demonstrate ARO-AAT Treatment Improved Multiple Biomarkers of Alpha-1 Liver Disease

Home > Press > Arrowhead Interim Clinical Data Demonstrate ARO-AAT Treatment Improved Multiple Biomarkers of Alpha-1 Liver DiseaseAbstract:- Serum Z-AAT reductions of 86-93%- All patients demonstrated greater than 80% reduction in liver Z-AAT monomer- 3 of 4 patients had a decrease in liver globule involvement- 3 of 4 patients demonstrated...

Predicting forces between oddly shaped nanoparticles

Nov 19, 2020 (Nanowerk News) Materials scientists at Duke University have devised a simplified method for calculating the attractive forces that cause nanoparticles to self-assemble into larger structures. With this new model, accompanied by a graphical user interface that demonstrates its power, researchers will be able to make previously impossible...